Noticias y Actividades de Otsuka Pharmaceutical
Presencia
Sede: Japón
Otsuka Holdings es una de las ...
Otsuka Holdings es una empresa que cotiza bajo el símbolo de cotización 4578 (JP).
Otsuka Holdings tiene presencia directa en 11 países.Otsuka Holdings posee 23 subsidiarias incluyendo Araris Biotech, Cambridge Isotope Laboratories y Interpharma.
Ellos se encuentran en:
- Farmacia46%
- Equipos médicos29%
- Otro25%
Fusión, adquisición y financiación con participación de Otsuka Holdings.
- Otsuka Pharmaceutical has announced the acquisition of Jnana Therapeutics (publicado el 1 de agosto de 2024).
Ejecutivos
Ver el organigrama con sus 175 ejecutivos principales
Biografías más buscadas en Otsuka Pharmaceutical
- Makoto Inoue, President and Representative Director
- Hiroshi Sugawara, Board Member
- Tatsuo Higuchi, Chairman and Representative Director
Recientes movimientos de ejecutivos en Otsuka Pharmaceutical
- Hiroaki Ono que ha sido Executive Managing Director of Pharmaceutical Business & Director, ha ascendido a Senior Executive Managing Director and Director (noticia publicada el 22 de mayo de 2026).
Crear su alerta
para seguir los movimientos de los ejecutivos en Otsuka Pharmaceutical.
Farmacia
Otsuka Holdings tiene 1.913 competidores entre los que se incluyen Sanofi (Francia), Eli Lilly (Estados Unidos) y Moderna (Estados Unidos).
Popular M&A news in Farmacia
- Contraline acaba de anunciar una recaudación de fondos de 93 millones de dólares. (publicado el 3 de junio de 2026).
- Hims & Hers ha Eucalyptus adquirido (publicado el 2 de junio de 2026).
- Apotex ha presentado su expediente de OPI. Su símbolo de cotización será TSX. (publicado el 2 de junio de 2026).
Otros contactos sugeridos en el sector Farmacia
Noticias
Últimos comunicados de prensa de Otsuka Pharmaceutical
- Otsuka Signs Joint Research Agreement with Keio UniversityIndustry-academia collaboration for infrastructure development toward the social implementation of psychedelics in Japan ｜News Releases | Otsuka Pharmaceutical Co., Ltd.
- Pharmavite Established a New Facility in Ohio, US, Dedicated to The Manufacturing of Gummy SupplementsFacilitating the Research and Development of Gummy Products｜News Releases | Otsuka Pharmaceutical Co., Ltd.
- Otsuka Pharmaceutical Opens First POCARI SWEAT Factory in VietnamSupporting Health and Meeting Growing Demand｜News Releases | Otsuka Pharmaceutical Co., Ltd.
- Otsuka Pharmaceutical is Focusing on "Water, Nutrition, and Oxygen" to Tap into Human PotentialProvide "Wellness Energy" at Expo 2025 in Osaka, Kansai, Japan｜News Releases | Otsuka Pharmaceutical Co., Ltd.
- Otsuka Files Biologics License Application (BLA) for Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy｜News Releases | Otsuka Pharmaceutical Co., Ltd.
- Rxulti® (brexpiprazole) approved in the European Union for the treatment of schizophrenia in adolescents aged 13 years and older｜News Releases | Otsuka Pharmaceutical Co., Ltd.
- Otsuka Pharmaceutical is Expanding "Local Production and Local Recycling" of PET Bottle Initiatives in Cooperation with Local CommunitiesAgreement Signed with the Saga Eastern Environmental Facilities Association for Horizontal Recycling of PET Bottle｜New
- HemeSight®, the First-in-Japan Comprehensive Genomic Profiling Assay for Hematological Malignancies, Is Now on Sale - Insurance coverage begins on March 1, 2025｜News Releases | Otsuka Pharmaceutical Co., Ltd.
- Otsuka Sponsor TOKYO MARATHON 2025 Supporting the Conditioning of Runners Worldwide with the Global Brand POCARI SWEAT｜News Releases | Otsuka Pharmaceutical Co., Ltd.
- Otsuka Holdings Receives Award by the Commissioner of the Consumer Affairs Agency at FY2024 Award for Good Practices of Consumer-Oriented Management - Recognized for Otsuka Pharmaceutical’s Longstanding Efforts to Prevent Heat Disorders- | Otsuka Group Ne
- View more press releases Close
Redes sociales sobre Otsuka Pharmaceutical
- Otsuka Pharmaceutical en Wikipedia, Google News y Yahoo Finance
- Otsuka Pharmaceutical en LinkedIn, Twitter y YouTube
